Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 16, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	3,156	7,601	3,129	3,015	1,945	1,754
Market Cap Growth	37.52%	142.94%	3.77%	55.05%	10.89%	-7.08%
Enterprise Value	3,348	7,793	3,255	3,130	2,127	1,985
Last Close Price	7.61	18.33	7.51	7.27	4.72	4.33
PE Ratio	-	-	-	334.55	-	-
Forward PE	-	18.69	18.69	18.69	18.69	18.69
PS Ratio	18.77	43.63	13.26	10.97	6.07	6.51
PB Ratio	7.93	18.47	6.04	5.19	3.43	2.93
P/TBV Ratio	9.64	22.66	7.47	6.83	4.83	4.09
P/OCF Ratio	-	-	268.82	119.56	82.56	-
EV/Sales Ratio	19.91	44.73	13.80	11.39	6.64	7.37
EV/EBITDA Ratio	-	-	205.51	235.43	451.32	-
EV/FCF Ratio	-71.23	-	-	-	-	-
Debt / Equity Ratio	0.53	0.67	0.36	0.38	0.31	0.37
Debt / EBITDA Ratio	-	-	11.75	16.80	37.71	-
Asset Turnover	0.22	0.22	0.28	0.31	0.36	0.29
Inventory Turnover	1.12	1.09	1.18	1.57	1.62	1.31
Quick Ratio	0.32	0.41	0.43	0.58	1.01	1.06
Current Ratio	0.80	0.88	0.97	0.79	1.53	1.53
Return on Equity (ROE)	-23.42%	-22.87%	-13.10%	-1.48%	-7.00%	-12.53%
Return on Assets (ROA)	-5.67%	-5.65%	-2.69%	-3.13%	-3.52%	-4.06%
Return on Capital (ROIC)	-6.92%	-6.45%	-3.05%	-3.57%	-3.96%	-4.53%
Earnings Yield	-2.52%	-1.03%	-1.62%	0.30%	-1.04%	-3.04%
FCF Yield	-1.49%	-0.86%	-1.20%	-0.26%	-0.42%	-3.54%
Payout Ratio	-	-	-	123.52%	-	-
Buyback Yield / Dilution	2.77%	2.53%	6.16%	-10.85%	0.91%	0.17%
Total Shareholder Return	-	2.53%	6.16%	-10.85%	0.91%	0.17%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.